ONCOLYTICS BIOTECH INC. Weighted Average Remaining Contractual Life Of Outstanding Share Options
ONCOLYTICS BIOTECH INC. (ONCY) had Weighted Average Remaining Contractual Life Of Outstanding Share Options of 4.99 year as of 2018-12-31, per its 20-F filed 2019-03-15.
Discontinued › Notes
ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions · last filed 2019-03-15
- 2018-12-31: Weighted Average Remaining Contractual Life Of Outstanding Share Options 4.99 year.
- 2017-12-31: Weighted Average Remaining Contractual Life Of Outstanding Share Options 7.09 year.
| Period end | Weighted Average Remaining Contractual Life Of Outstanding Share Options |
|---|---|
| 2018-12-31 | 4.99 year 20-F · filed 2019-03-15 |
| 2017-12-31 | 7.09 year 20-F · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |